Michael Christian
1.8K posts


@BlindOnUni @TomiLahren @ABC You’re an idiot and that’s not hyperbole. But your comment is. I’ve saved multiple “small breed” and others from shelters. This is my current. Maltipoo rescue. Stop being so ignorant

English

@TomiLahren @ABC Only dogs you can find in the shelter are pit bulls and pit mixes. No thank you. I like having my limbs intact.
English

Americans still dig French bulldogs, retrievers and German shepherds. But dachshunds are increasingly hot dogs. abcnews.link/OlhspUz
English

@AdamSinger Maybe they went to the Early Childhood Learing Center
English

@bglangner @JohnDoeKnowsGuy Andres is like that crazy uncle that shows up on thanksgiving in his 78 trans am and telling stories about his recent trip to Bangkok
English

@JohnDoeKnowsGuy I don't want him to be fired for the same reason that I don't block certain accounts on here who have absolutely wild takes and ridiculous opinions on certain topics or people or companies that I follow, no matter how absurd. Life would be dull otherwise
English

Lol at what he hears from physicians. You can literally go to any social media site with a PAH group and see that he is wrong $lqda. This dude should be fired.
Jonathan Faison@jfais20
$LQDA- Where do they get these guys from 😂
English

The idiot threatened by a little white furball.
Have any of you idiots ever been to a dog beach? Dogs rush up and smell each other. Should the dog be on a leash, yeah. They still would've met and sniffed each other
That wasn't where the problem started. The guy kicking the dog is an asshole. He deserved to get punched.
English

@from1to3000000 @Ignacio_BML I owe him a beer. One of his reports tanked the stock and I scooped a ton of calls. Though I may pour that beer over his head, I still owe him one. 🤪🫃🤡
English

The Oppenheimer "analyst" who covers $LQDA is more of a $UTHR activist who was previously at Wedbush. For years he had a price target of $4 on $LQDA and then went to $3 and reiterated an underperform every quarter. Then he went to Oppenheimer. (likely forced out of Wedbush). Then when it was in the $20 area he went to $6 or something, then it went to $40 and he went to $16 lol.
English

@IchBinDeutsch_ @YetiMoose @housecor Where does a family of 4 sit if the back seats are down for luggage?
English

I don’t thunk enough people realize how much cheaper an EV can be to operate.
Today I took a 200 mile trip.
My gas SUV gets 20 mpg highway. So I’d have spent $35 on gas.
Instead, I took my EV. It used just $2.40 in electricity.
Over 14x cheaper!
And the EV is smoother, quieter, easier to maintain, and MUCH quicker.

English

$LQDA at 17% market share. This clown had a $3 p/t and blamed “channel checks”. How are your “checks” now? #UTHR shill.

English

I recommend all $UTHR and $LQDA investors to listen to UTC Q4 CC first and then $LQDA's Q4 CC.
1. RJ and team are not selling snake oil.
2. RJ and team are far scientific and sophisticated.
3. SMI is just nebulizer with better probability.
4. Relanipeg is just Uptravi in once a day format with worse AEs.
5. Yutrepia is having one of the best launches in the past 5 years.
6. $1B+ product in 2027.
7. No seasonal slow-down.
8. UTC in full panic and desperation.
9. Oral to Yutrepia interest growing.
10. Sota + Yutrepia growing and study coming.
11. Liquidia is all in for the patients.
English

@drjjlevine I tell everyone who rides with me. It’s the most polite car ever. It will change human behavior. No road rage, no cutting off , no tailgating or reckless driving. Just transportation. Point A to point B. No drama.
English

71 mph in the lane.
Blue Hyundai Santa Fe signals.
Wants in.
My Tesla FSD robot sees it before it’s awkward.
Gently lifts off.
Creates space.
Lets him slide in smooth.
No drama.
No ego.
No “this is my lane” energy.
Just intelligent, polite driving at highway speed.
The future isn’t flashy.
It’s courteous.
$TSLA
English

@DaveWangMIA @ElsaSofia__AI Who doesn’t need a $25k/mo messaging system??
English

@ElsaSofia__AI No. Claude doesnt replace a Bloomberg terminal
Bloomberg gives you real-time data feeds, execution, compliance, and a messaging network with 350K finance professionals. Claude is incredible for analysis but it cant replace what it cant access. Use both together
English

@theglobecoded @WallStreetMav Kinda like posting and complaining anonymously. I bet you’re a big hit with the boys.
English

Oh wow, big tough guy energy, bulldozing tiny Venezuela and Iran like it's Call of Duty on easy mode, now eyeing Cuba and dreaming of NATO liberation. 😂 Meanwhile, remember when the same invincible military ran from Afghanistan so fast they gifted the Taliban $85B in free gear?
Classic tough-guy move: beat up the weak kids, then ghost when the real fight shows up. Keep flexing tho, champ.
English

@baltimoresun You obviously haven’t been paying attention to Gavin newsoms account and his profanity. Double standard?
English

Reader commentary: Our Olympians deserve support, but Jimmy's Famous Seafood's profane way of coming to their defense shouldn't be celebrated. bit.ly/4u1O2bu
English

@Gage_Jordan @AlphaHunte79332 This “announcement “ is also antithetical to Martines motto of “approve and improve”. They have sat on this for 20 years? I’d love to hear an answer to that question from an analyst. “Why now?”
English

@AlphaHunte79332 Hopefully she talks more and sends $LQDA lower. More shares for me to buy
GIF
English

What Martine did here was rather incredible.
She took what should have been the thrown in the towel moment as Tyvaso stops growing as a result of Yutrepia and pretended like she had a magic trick up her sleeve with a new product. She spoke in over the top terms and is a great story teller and has analysts who don’t push back and so rather than her stock being done 30% - it was up 10%.
Let’s be clear about a few facts. $UTHR has never registered this new product for any clinical trials. The data they have is from 20 years ago when they did three separate studies totally 168 patients (this is according to the US9,358,240 patent) and patented mist inhalers. In other words, this is just old shelved data that they are trying to resurrect.
Let’s be clear the mist inhaler probably has less cough issues than Tyvaso, but it loses on titratability and other factors and titratability as we see is the key thing that matters. $UTHR has had this form factor patented for 20 years and decided to never go with it. What has changed is that $LQDA has successfully exploited their flawed inhaler with Yutrepia. Their inhaler has cough issues that Yutrepia does not.
This is just a distraction - there is no data and no product really. By the time this product comes out, its patent would already be expired. Furthermore, by then $LQDA will be much closer to launching L606, which will make this all moot.
This is just a CEO trying to keep her stock price from plummeting while growth reverses in her main product. If this form factor was a killer app - they would have gone with it 20 years ago when they patented it. They would have chosen it instead of DPI. They have had the data and sat on it for 20 years. That is why they are not presenting data.
All of this will of course become clear in the coming days as funds do work on this. Roger will surely spell this out on the call.
English











